Omeros Corp. (Nasdaq: OMER) narrowed losses for the third quarter to 16 cents per share from losses of 34 cents per share in the year ago period. Shares of the biopharmaceutical surged $4.08 to close at $18.17.
Omeros narrows losses
November 10, 2017 at 17:10 PM EST
